After Illumina CEO’s Fall, Other Executives May Take Hard Look Before Deal Making
Wall Street Journal
Francis deSouza resigned from gene-sequencing maker after regulators challenged $7.1 billion deal, triggering proxy battle with Carl Icahn.
Understanding current events through the lenses of the past and future.
Wall Street Journal
Francis deSouza resigned from gene-sequencing maker after regulators challenged $7.1 billion deal, triggering proxy battle with Carl Icahn.